Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support
Portfolio Pulse from Vandana Singh
The FDA has recommended updated monovalent COVID vaccines targeting the XBB variants for the fall and winter. Pfizer, Moderna, and Novavax are gearing up to produce vaccines targeting the XBB.1.5 strain.

June 16, 2023 | 12:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioNTech is collaborating with Pfizer to develop COVID-19 vaccines targeting the XBB.1.5 strain.
The FDA's recommendation for updated vaccines targeting the XBB variants will likely increase demand for BioNTech's vaccine. Collaborating with Pfizer will help BioNTech develop an effective vaccine for the XBB.1.5 strain, potentially boosting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Moderna plans to supply a new vaccine targeting the XBB.1.5 strain later this year.
The FDA's recommendation for updated vaccines targeting the XBB variants will likely increase demand for Moderna's vaccine. Developing a vaccine for the XBB.1.5 strain will help Moderna stay competitive in the market, potentially boosting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Novavax plans to have a vaccine targeting the XBB.1.5 strain ready for distribution in the fall.
The FDA's recommendation for updated vaccines targeting the XBB variants will likely increase demand for Novavax's vaccine. Developing a vaccine for the XBB.1.5 strain will help Novavax stay competitive in the market, potentially boosting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Pfizer is collaborating with BioNTech to develop COVID-19 vaccines targeting the XBB.1.5 strain.
The FDA's recommendation for updated vaccines targeting the XBB variants will likely increase demand for Pfizer's vaccine. Collaborating with BioNTech will help Pfizer develop an effective vaccine for the XBB.1.5 strain, potentially boosting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100